HCW Biologics Inc.

HCWB Healthcare Biotechnology

HCW Biologics Inc.’s revenue for fiscal 2025 (year ended December 2025) was $54,200.00, down 97.9% from fiscal 2024. In the quarter to June 2026, revenue grew 1,954.6%, EPS grew 71.6%, free cash flow fell 20.8% and total debt fell 3.34%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

1.24 0.01 +0.81%
Market cap
$2.8M
P/E
0.0×
Fwd P/E
−3.4×
Dividend yield
—
F-score
3/9
Altman Z
−8.83
Beneish M
−9.28
Dividend safety
n/a
Dec '17 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
— — — — — — 3 3
P/E ratio
— — 0.00 — 0.00 0.00 0.00 0.00
Altman Z-Score
— — — — 2.91 (4.68) (8.45) (8.83)
P/S ratio
— — 0.00 — 10.45 15.17 6.74 37.55
Altman Z″-Score (non-manufacturers)
— — (1.88) — 3.21 (13.72) (22.77) (22.93)
P/FCF ratio
— — 0.00 — 0.00 0.00 0.00 0.00
Beneish M-Score
— — — — — 3.67 (6.27) (9.28)
P/Operating CF
— — (31.30) — (18.53) (11.07) (6.11) (0.61)
P/B ratio
— — 0.00 — 1.88 3.20 0.00 0.74
EV/Sales
— — 0.00 — 6.63 16.18 10.26 133.75
EV/EBITDA
— — 0.00 — 0.00 0.00 0.00 0.00
EV/FCF
— — (2.90) — (2.16) (1.60) (1.82) (0.53)
Current Ratio
— 7.53 12.14 17.44 11.52 0.73 0.19 0.11
Net Debt/EBITDA
— 1.06 1.50 2.86 1.79 (0.11) (0.32) (0.40)
Debt/Equity
— 0.00 (0.03) 0.00 0.17 0.47 (2.02) 2.46
ROE
— 58.97% 53.60% (74.62%) (33.63%) (98.23%) (897.37%) 1,113.43%
ROA
— (154.63%) (55.56%) (37.33%) (29.71%) (66.37%) (102.21%) (81.45%)
ROIC
— 0.00% 0.00% (57.70%) (80.03%) (99.40%) (819.04%) (107.94%)
Return on Tangible Assets
— (86.80%) (55.43%) (32.75%) (35.55%) (138.02%) 2,942.07% (1,060.53%)
Average Days of Receivables
— — 222.57 0.00 22.68 197.26 82.79 216.85
Earnings Yield
— — (38.19%) — (21.38%) (58.32%) (131.14%) (1,214.07%)
Free Cash Flow Yield
— — (28.82%) — (29.42%) (66.61%) (83.71%) (669.68%)
Free Cash Flow per Share
— (0.18) (538.98) (140.96) (138.39) (191.83) (89.60) (38.29)
Book value per Share
— 0.25 (848.65) 654.64 250.69 89.92 (41.87) 7.91
Free Cash Flow
— (6.77) (10.62) (11.02) (20.66) (28.72) (14.49) (13.39)
EV/EBIT
— — 0.00 — 0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates